BDTX-189
BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations (KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively) . BDTX-189 exhibits anticancer activity.
Product Specifications
CAS Number
2414572-47-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
561.03
Molecular Formula
C29H29ClN6O4
Notes
Research use only, not for human use.
Receptor
BLK|EGFR|HER2|RIPK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog